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1. General Experimental Procedures. 1D and 2D NMR spectra were recorded on a Brucker 700 Avance III HD ( 1 H NMR -700.47 MHz; 13 C NMR 176.13 MHz) in CDCl 3 : δ in ppm, J in Hz. Low resolution electrospray ionisation mass spectrometry measurements (LRESIMS) were recorded in positive or negative ionization mode on a Bruker Esquire HCT (High Capacity 3D ion trap) instrument with a Bruker ESI source. High resolution electrospray ionisation (HRESIMS) accurate mass measurements were recorded in positive mode on a Bruker MicrOTOF-Q (quadrupole -Time of Flight) instrument with a Bruker ESI source. Accurate mass measurements were carried out with external calibration using sodium formate as reference calibrant.
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